A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib. - Wang, Huaxiang; Li, Junjun; Zhu, Xiuling; Wang, Ruling; Wan, Yunyan (Scientific Reports, 2025)